SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

Silver is trending after a parabolic ascent driven by strong industrial demand for technologies like EVs and solar panels, alongside geopolitical tensions and a significant premium observed in overseas markets. This rapid climb has been met with extreme volatility and a notable pullback following multiple increases in COMEX margin requirements. The community is sharply divided, with many seeing this dip as a buying opportunity based on a long-term supply deficit, while others warn of a speculative bubble potentially unraveling.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is experiencing significant volatility and community speculation following recent policy discussions impacting the healthcare sector and an announcement regarding ACA profits. Ahead of its upcoming earnings report, investors are sharply divided between those concerned about potential regulatory headwinds and others anticipating a rebound, viewing recent price movements as a strategic shakeout before a long-term recovery.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is experiencing dramatic upward movement following news of an exclusive AI licensing partnership to commercialize its Engagement Language Model in Africa. This has sparked intense community discussion about a potential short squeeze, with traders anticipating further parabolic gains amidst significant short interest. The rally is further amplified by broad market enthusiasm for AI-driven solutions and infrastructure plays.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending following news of a significant U.S. government investment and private capital raise to develop domestic rare earth capabilities. This substantial backing, designed to secure the nation's critical mineral supply chain, has sparked considerable community excitement, drawing comparisons to past government-supported plays. While many anticipate long-term growth and potential for a short squeeze, others are cautious due to recent price volatility, profit-taking, and discussions surrounding share dilution.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending due to overwhelming community anticipation for the imminent NASA Lunar Terrain Vehicle (LTV) contract award, which is widely expected to solidify its position as a dominant player in the lunar economy. Despite some frustration over the delayed announcement and recent market volatility across the space sector, many investors maintain strong conviction, viewing dips as key buying opportunities ahead of the significant catalyst.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to its strategic acquisition of SkyWater Technology, a move aimed at vertical integration to accelerate its quantum computing hardware development. This has sparked varied community perspectives, with many viewing it as a transformative step towards in-house manufacturing and potential government contracts. However, others express concerns regarding the financial implications and the long-term commercialization strategy within the nascent quantum sector.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is a major talking point amid regulatory scrutiny affecting Medicare Advantage payment outlooks and uncertainty surrounding health care subsidies, leading to strategic market adjustments for 2026. Recent legal challenges regarding Medicare bonus payments and analyst sentiment have amplified a polarized investor debate, with some predicting significant industry headwinds while others view current price levels as a compelling buying opportunity. The broader health insurance sector is navigating increasing medical costs and a dynamic regulatory environment, prompting strategic realignments across major players.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing a surge in conversation and trading volume after Michael Burry disclosed buying shares, fueling intense community speculation. This news, combined with recent insider purchases, has reignited discussions among retail traders about both the stock's long-term value and the potential for significant market movement.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is trending amid an explosive surge in silver prices, fueled by strong industrial demand, upcoming export restrictions from China, and speculation of a short squeeze. While many celebrate "parabolic" gains and "generational" opportunities, others caution that the rally is an unsustainable "bubble" poised for a "bloodbath" correction. This leveraged ETF amplifies the intense volatility, drawing sharply divided opinions and aggressive trading from both bullish and bearish camps.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is trending as investors anticipate its annual Qubits conference and digest the recent Quantum Circuits acquisition, which aims to accelerate its gate-model quantum computing capabilities. Community sentiment is sharply divided, with proponents hailing D-Wave's technological advancements and dual-platform strategy for market leadership, contrasting with critics who emphasize extreme valuation concerns, ongoing dilution, and insider selling. This polarization underscores the speculative yet potentially transformative outlook for the quantum computing sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mitsubishi UFJ Trust & Banking Corp Sells 198,889 Shares of Royalty Pharma PLC $RPRX

Mitsubishi UFJ Trust & Banking Corp reduced its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 11.6% in the third quarter, according to its most recent filing with the SEC...

Cullen Frost Bankers Inc. Raises Position in Royalty Pharma PLC $RPRX

Cullen Frost Bankers Inc. boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 44.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and...

Dianthus Therapeutics, Inc. (DNTH) Moves 9.9% Higher: Will This Strength Last?

Dianthus Therapeutics, Inc. (DNTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Lightning Round: Coherent is a winner, says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: Steel Dynamic, Royalty Pharma, Coherent, Lucid, and more...

Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 20,000 Shares

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of Royalty Pharma stock in a transaction dated Friday, January 16th. The shares were sold at an average price...

Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $790,400.00 in Stock

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the company's stock in a transaction on Friday, January 16th. The stock was sold at an average price of...

Sumitomo Mitsui Trust Group Inc. Buys 207,338 Shares of Royalty Pharma PLC $RPRX

Sumitomo Mitsui Trust Group Inc. raised its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 23.2% during the 3rd quarter, according to its most recent disclosure with the Securities and...

Royalty Pharma (NASDAQ:RPRX) Raised to "Strong-Buy" at Wall Street Zen

Wall Street Zen raised Royalty Pharma from a "buy" rating to a "strong-buy" rating in a report on Saturday...

Nordea Investment Management AB Acquires 120,004 Shares of Royalty Pharma PLC $RPRX

Nordea Investment Management AB grew its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 18.3% during the third quarter, according to its most recent 13F filing with the Securities and...

Terrance Coyne Sells 69,582 Shares of Royalty Pharma (NASDAQ:RPRX) Stock

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) CFO Terrance Coyne sold 69,582 shares of Royalty Pharma stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an...

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Royalty Pharma plc - Ordinary Shares - Class A

No change

25 bps cut

25 bps hike

Note sure, just watching

The Fed announces its rate decision this Wednesday.

Markets are pricing in a ~99% chance of no change at this week’s Fed decision, according to prediction markets. $SPY $QQQ 

FOMC on Wednesday, what do you think the Fed will decide?

RPRX
Royalty Pharma plc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RPRX News

RPRXRoyalty Pharma plc - Ordinary Shares - Class A